Panto Tad (Pantoprazole)

Pantoprazole, the active ingredient in Panto Tad, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and ulcer healing in adults. GNH USA supplies Panto Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief and healing in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes mucosal healing. - Erosive oesophagitis: heals erosive lesions and prevents recurrence. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to pantoprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing pantoprazole, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate need for long‑term therapy: weigh benefits against fracture risk. - Monitor electrolytes: especially magnesium during prolonged use. - Pregnancy and lactation: use only if clearly needed. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration in INR values. - Digoxin: increased serum concentrations. - Methotrexate (high dose): reduced renal clearance.